Internal Medicine, Rheumatology · Philadelphia, PA
NPI
1578583332
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3400 Spruce Street
Philadelphia, PA, 19104
Phone (215) 662-2454
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,569 services
Medicare patients, 2024
566
Average age 72
Drug cost, 2024
$1.6M
3,230 prescriptions
Company payments, 2025
$29K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nora Sandorfi was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 456 times for 342 patients. In total Nora Sandorfi billed 1,569 services in 19 codes, and Medicare paid $85K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 456 | 342 | $12.90 | $5,883 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 233 | 167 | $12.61 | $2,937 |
| 99214 Office E&M - Established | Office | 206 | 179 | $69.62 | $14K |
| 99215 Office E&M - Established | Office | 201 | 149 | $103.47 | $21K |
| 99215 Office E&M - Established | Facility | 141 | 97 | $104.55 | $15K |
| 99214 Office E&M - Established | Facility | 114 | 93 | $64.62 | $7,367 |
| 99205 Office E&M - New | Office | 45 | 45 | $129.02 | $5,806 |
| 99213 Office E&M - Established | Office | 42 | 39 | $50.55 | $2,123 |
| 99205 Office E&M - New | Facility | 31 | 31 | $132.88 | $4,119 |
| 99204 Office E&M - New | Office | 18 | 18 | $106.85 | $1,923 |
| 99204 Office E&M - New | Facility | 13 | 13 | $99.72 | $1,296 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $51.05 | $664 |
By year: 2022 $69K for 840 services; 2023 $78K for 852 services; 2024 $85K for 1,569 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nora Sandorfi prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 535 prescriptions and refills. In total Nora Sandorfi wrote 3,230 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 535 | 1,067 | 125 | $19K |
| Methotrexate Methotrexate Sodium | 280 | 469 | 55 | $4,185 |
| Prednisone Generic | 256 | 315 | 55 | $1,395 |
| Alendronate Sodium Generic | 216 | 401 | 53 | $2,060 |
| Gabapentin Generic | 136 | 195 | 33 | $1,806 |
| Hydrochlorothiazide Generic | 122 | 249 | 29 | $482 |
| Pilocarpine Hcl Generic | 119 | 163 | 31 | $6,590 |
| Mycophenolate Mofetil Generic | 116 | 203 | 30 | $9,673 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 97 | 98 | 11 | $2,573 |
| Risedronate Sodium Generic | 86 | 145 | 19 | $4,335 |
| Cevimeline Hcl Generic | 74 | 154 | 22 | $17K |
| Omeprazole Generic | 72 | 152 | 24 | $875 |
| Leflunomide Generic | 57 | 89 | 11 | $2,798 |
| Sulfasalazine Generic | 53 | 81 | Under 11 | $738 |
| Cyclobenzaprine Hcl Generic | 38 | 46 | Under 11 | $599 |
Brand drugs: 329 claims; generic drugs: 2,901 claims; opioid claims: 219.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nora Sandorfi $29K ($29K in general payments such as food, travel and fees) from 5 companies. The largest payer was Novartis Pharmaceuticals Corporation with $17K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.